Carmignac

2022: a year of active stewardship illustrated

  • Published
  • Length
    5 minute(s) read
  • 81
    Engagements held
  • 98%
    Meetings voted
  • 55%
    Of meetings where Carmignac voted against management at least once


  • Carmignac held 81 engagements in 2022:

  • Carmignac
  • In 2022, Carmignac voted against the management of our investee companies at least once at 55% of the meetings we voted compared to 41% in 2021:

  • Carmignac

The engagements presented below were undertaken in Q4 2022.

Experian

Sector: Professional services
Region: Europe

The Company is held in a number of Carmignac’s equity funds1 .

Teva Pharmaceutical Industries

Sector: Pharmaceuticals
Region: Middle East

The Company is held in a number of Carmignac’s fixed income funds4 .

1As at the date of the engagement reported (November 2022) and the date of publication of this case study (January 2023). Equity funds are Carmignac Grande Europe and Carmignac Portfolio Europe Patrimoine. 2https://carmidoc.carmignac.com/ESGEP_INT_en.pdf

3The proprietary ESG system START combines and aggregates market leading data providers ESG indicators. Given the lack of standardisation and reporting of some ESG indicators by public companies, not all relevant indicators can be taken into consideration. START provides a centralised system whereby Carmignac’s proprietary analysis and insights related to each company are expressed, irrespective of the aggregated external data should it be incomplete. For more information, please consult our ESG Integration Policy: https://carmidoc.carmignac.com/SRIIP_INT_en.pdf

4As at the date of the engagement reported (October 2022) and the date of publication of this case study (January 2023). Fixed income funds are Carmignac Credit 2025, Carmignac Credit 2027, Carmignac Portfolio Evolution, Carmignac Portfolio Global Bond, Carmignac Patrimoine, FP Carmignac Patrimoine, Carmignac Portfolio Patrimoine Europe, Carmignac Sécurité, Carmignac Portfolio Sécurité, Carmignac Profil Réactif 50, Carmignac Profil Réactif 75, Carmignac Profil Réactif 100.

5The proprietary ESG system START combines and aggregates market leading data providers ESG indicators. Given the lack of standardisation and reporting of some ESG indicators by public companies, not all relevant indicators can be taken into consideration. START provides a centralised system whereby Carmignac’s proprietary analysis and insights related to each company are expressed, irrespective of the aggregated external data should it be incomplete. For more information, please consult our ESG Integration Policy: https://carmidoc.carmignac.com/SRIIP_INT_en.pdf

To find out more on our responsible investment philosophy, please visit our Responsible Investment section:

Responsible Investment
Thank you for taking the time to provide your feedback, appreciated.

This is a marketing communication. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents. Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. UK:This document was prepared by Carmignac Gestion and/or Carmignac Gestion Luxembourg and is being distributed in the UK by Carmignac Gestion Luxembourg UK Branch (Registered in England and Wales with number FC031103, CSSF agreement of 10/06/2013). In Switzerland: the prospectus, KIIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Paris, succursale de Nyon/Suisse, Route de Signy 35, 1260 Nyon. ​Copyright: The data published in this presentation are the exclusive property of their owners, as mentioned on each page. CARMIGNAC GESTION 24, place Vendôme - F-75001 Paris - Tél : (+33) 01 42 86 53 35 Investment management company approved by the AMF Public limited company with share capital of € 15,000,000 - RCS Paris B 349 501 676 CARMIGNAC GESTION Luxembourg - City Link - 7, rue de la Chapelle - L-1325 Luxembourg - Tel : (+352) 46 70 60 1 Subsidiary of Carmignac Gestion - Investment fund management company approved by the CSSF Public limited company with share capital of € 23,000,000 - RC Luxembourg B 67 549